miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model

• Main Authors: Elisa Callegari (Author), Lucilla D'Abundo (Author), Paola Guerriero (Author), Carolina Simioni (Author), Bahaeldin K. Elamin (Author), Marta Russo (Author), Alice Cani (Author), Cristian Bassi (Author), Barbara Zagatti (Author), Luciano Giacomelli (Author), Stella Blandamura (Author), Farzaneh Moshiri (Author), Simona Ultimo (Author), Antonio Frassoldati (Author), Giuseppe Altavilla (Author), Laura Gramantieri (Author), Luca Maria Neri (Author), Silvia Sabbioni (Author), Massimo Negrini (Author)
• Format: Book
• Published: Elsevier, 2018-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Prognosis is poor, and therapeutic options are limited. MicroRNAs (miRNAs) have emerged as potential therapeutic molecules against cancer. Here, we investigated the therapeutic efficacy of miR-199a-3p, an m...